Treatment of severe hypertension with minoxidil: advantages and limitations

Journal of Clinical Pharmacology
V M CampeseV DeQuattro

Abstract

Minoxidil, a new peripheral vasodilator, was used in the therapy of 26 hypertensives who were previously uncontrolled on conventional medications or who had dose-limiting side effects. Minoxidil provided (1) therapeutic advantages in all patients, regardless of the etiology of their hypertension, (2) no symptoms of orthostatic hypotension or sympathetic nervous system depression, (3) a simplification of medical regimens and perhaps costs, and (4) regression of impotence in four out of seven patients. The major limiting factors encountered were (1) fluid retention with the development of congestive heart failure in three patients, (2) pericardial effusion in three patients, and (3) hypertrichosis, which reduced its acceptability in female patients.

References

Feb 1, 1975·The Journal of Clinical Investigation·W A Pettinger, K Keeton
May 1, 1975·Acta Medica Scandinavica·R SannerstedtL Werkö
May 26, 1977·The American Journal of Cardiology·R K BryanJ M Purdy
Jul 1, 1976·Kidney International·J T Fitzsimons
Sep 1, 1975·American Heart Journal·J C DormoisA S Nies
Jul 21, 1975·JAMA : the Journal of the American Medical Association·P K MehtaG Dunea
Jul 26, 1973·The New England Journal of Medicine·W A Pettinger, H C Mitchell
May 1, 1972·Clinical Pharmacology and Therapeutics·T B GottliebC A Chidsey

❮ Previous
Next ❯

Citations

Mar 1, 1981·European Journal of Clinical Pharmacology·D ChuR Amrein
Dec 1, 1989·Journal of the American College of Cardiology·G L Bakris, E D Frohlich
Jun 21, 2001·The Journal of Clinical Hypertension·D A Sica, T W Gehr
Sep 7, 2000·Journal of Clinical Pharmacology·E Basta, G L Bakris
Jan 1, 1982·Journal of Pharmacological Methods·S J Humphrey, R B McCall
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·V DeQuattro, R Hamad
Aug 1, 1985·Journal of the American Academy of Dermatology·E A OlsenS R Pinnell
May 3, 2006·Journal of Pharmacological and Toxicological Methods·Dennis J MurphyHaisong Ju
Jun 1, 1997·Clinical Pharmacology and Therapeutics·C M SteinA J Wood
May 11, 2004·The Journal of Clinical Hypertension·Domenic A Sica
Jun 30, 2006·Hemodialysis International·Rajiv Agarwal
Mar 1, 1988·Hypertension·M H AldermanW L Ooi
Jul 1, 1980·Klinische Wochenschrift·A MeierF C Reubi
Jul 6, 2020·Journal of the American Academy of Dermatology·Michael Randolph, Antonella Tosti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Clinical and Experimental Dermatology
M GonzálezJ L Díaz Pérez
Journal of the American Academy of Dermatology
J A KoperskiE K Orenberg
© 2021 Meta ULC. All rights reserved